Evaluation of Agreement Between CT Scan and 3D-DXA Measurements on the Lombar Spine (3D DXA SPINE)

September 27, 2022 updated by: Centre Hospitalier Universitaire de Nīmes
Dual-energy X-ray Absorptiometry is frequently used to measure bone mineral density. A new medical device, Box 3D DXA, creates a 3D image using a statistics reconstruction model developed on the femur. This new imaging technique does not require additional irradiation and ought to improve bone measures as well as incorporating densitometric parameters into the diagnosis. This study will test the reconstruction of the 3D image from lombar spine measurements and compare accuracy against measurements made using CT scan.

Study Overview

Status

Active, not recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

120

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Nîmes, France, 30029
        • CHU Nîmes

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • The patient must have given their free and informed consent and signed the consent form
  • The patient must be a member or beneficiary of a health insurance plan
  • The patient is at least 18 years old
  • The patient has been referred by a doctor for a PET/CT (Positron Emission Tomography-Computed Tomography) scan or a SPECT (Single Photon Emission Computed Tomography) scan in the Nuclear Medicine and Medical Biophysics Department of Nimes hospital or a bone scan including a SPECT/CT (single photon emission computed tomography coupled with a CT scan)

Exclusion Criteria:

  • The subject is participating in an interventional study, or is in a period of exclusion determined by a previous study
  • The subject refuses to sign the consent
  • It is impossible to give the subject informed information
  • The patients is under judicial protection or state guardianship
  • The patient is pregnant or breast feeding
  • The subject has a observably serious scoliosis
  • Subject has previously had spinal or hip surgery
  • Subject weighs more than 200kg and/or is more than 2 meters tall by 5+65cm wide and 70cm diameter
  • Patient uses an insulin pump or wears an insulin or morphine tubing or any attenuating equipment affecting the hips or lumbar spine
  • Subject has already had an X-ray exam using a contrast product such as barium in the 7 days preceding the visit
  • Subject having undergone γ radiation exam in the 15 days preceding the visit

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: 2nd lumbar spine acquisition in same position
spine and hip STRATOS DR + 2nd lumbar spine acquisition in same position (with template)
Two dual-energy X-ray scans + CT scan
Active Comparator: 2nd lumbar spine acquisition
spine and hip STRATOS DR + 2nd lumbar spine acquisition (no template)
Two dual-energy X-ray scans + CT scan
Active Comparator: 2nd hip acquisition in same position
spine and hip STRATOS DR + 2nd hip acquisition in same position (with template)
Two dual-energy X-ray scans + CT scan
Active Comparator: 2nd hip acquisition
spine and hip STRATOS DR + 2nd hip acquisition (without template)
Two dual-energy X-ray scans + CT scan

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Concordance in lombar spine measurements between box 3D-DXA (index test) and CT scan (reference test)
Time Frame: Day 0
Lin's concordance coefficient
Day 0
Concordance in lombar spine measurements between box 3D-DXA (index test) and CT scan (reference test)
Time Frame: Day 0
Bland Altman plot
Day 0

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Reproducibility of the 3D-DXA Spine algorithm for lombar spine measurements
Time Frame: Day 0
2 acquisitions under the same conditions. Using root-mean-square coefficient of variation to calculate the Least Significant Change
Day 0
Robustness of 3D-DXA Spine measurement for lombar spine measurements
Time Frame: Day 0
2 acquisitions under the same conditions. Using interquartile range as a measure of dispersion of the variable
Day 0
Concordance in femur measurements between box 3D-DXA (index test) and CT scan (reference test)
Time Frame: Day 0
Lin's concordance coefficient
Day 0
Concordance in femur measurements between box 3D-DXA (index test) and CT scan (reference test)
Time Frame: Day 0
Bland Altman plot
Day 0
Reproducibility of the 3D-DXA Femur algorithm for femur measurements
Time Frame: Day 0
2 acquisitions under the same conditions. Using root-mean-square coefficient of variation to calculate the Least Significant Change
Day 0
Robustness of 3D-DXA Femur measurement for femur measurements
Time Frame: Day 0
2 acquisitions under the same conditions. Using interquartile range as a measure of dispersion of the variable
Day 0

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 26, 2019

Primary Completion (Actual)

August 20, 2021

Study Completion (Anticipated)

December 1, 2022

Study Registration Dates

First Submitted

August 2, 2018

First Submitted That Met QC Criteria

August 16, 2018

First Posted (Actual)

August 20, 2018

Study Record Updates

Last Update Posted (Actual)

September 28, 2022

Last Update Submitted That Met QC Criteria

September 27, 2022

Last Verified

September 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • LOCAL/2016/VB-01

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Bone Fracture

Clinical Trials on DXA + CT

3
Subscribe